RE-BVS – Piemonte Repository

Sfoglia per AUTORE
VALERI N
Collezione AOU Novara

Items : 3

Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2025 Feb 17;31(4):707-718. doi: 10.1158/1078-0432.CCR-24-0924.

2025
AOU Novara

Ghidini M; Hahne JC; Senti C; Heide T; Proszek PZ; Shaikh R; Carter P; Hubank M; Trevisani F; Garrone O; Cappelletti MR; Generali D; Cattaneo M; Gnocchi N; Donati G; Gobbi A; Grizzi G; Lampis A; Elghadi R; Tanzi G; Tomasello G; Ratti M; Pinato DJ; Fassan M; Vlachogiannis G; Sottoriva A; Cortellini A; Passalacqua R; Valeri N; et alii...

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2024 May 15;30(10):2140-2159. doi: 10.1158/1078-0432.CCR-23-2748.

2024
AOU Novara

Hedayat S; Cascione L; Cunningham D; Schirripa M; Lampis A; Hahne JC; Tunariu N; Hong SP; Marchetti S; Khan K; Fontana E; Angerilli V; Delrieux M; Nava Rodrigues D; Procaccio L; Rao S; Watkins D; Starling N; Chau I; Braconi C; Fotiadis N; Begum R; Guppy N; Howell L; Valenti M; Cribbes S; Kolozsvari B; Kirkin V; Lonardi S; et alii...

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer. in Nature medicine / Nat Med. 2023 Mar;29(3):605-614. doi: 10.1038/s41591-023-02240-8. Epub 2023 Mar 2.

2023
ASL Torino 4
AOU Novara

Tamburini E; Petrillo A; Gobba SM; Graham J; Longarini R; Garrone O; Zanaletti N; De Tursi M; Parisi A; Libertini M; Morelli C; Cergnul M; Depetris I; Ratti M; Fenocchio E; Zoratto F; Thomas A; Iveson T; Messina C; Pavarana M; Ross P; Rodriquenz MG; Stavraka C; Rosati G; Antonuzzo L; Mazzuca F; Merz V; Gelsomino F; Berardi R; et alii...